PERSPECTA

News from every angle

← Back to headlines

ImmunityBio Faces Securities Fraud Class Action Lawsuit

Investors in ImmunityBio, Inc. (IBRX) are presented with an opportunity to lead a securities fraud class action lawsuit against the company.

19 Apr, 19:22 — 19 Apr, 19:22
PostShare

Sources

Showing 1 of 1 sources
globe-and-mailHigh120d ago

ImmunityBio, Inc. (IBRX) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - The Globe and Mail

ImmunityBio, Inc. (IBRX) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit  The Globe and Mail

Read full article →

Related Stories

Cornerstone Funds Declare Monthly Dividends and Announce 2026/2027 Distributions

3h ago

The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results

5h ago

Mark Cuban and Tech Founders Oppose California Wealth Tax Proposal

7h ago

Greece to Save €2 Billion by Early Debt Repayment in 2026

8h ago